It is a pharma private limited company based in New Delhi, Delhi, India, established in 2012.
2012 | New Delhi, Delhi, India | ActiveNovomax Pharma Private Limited, a active private limited company, was established on 28 June 2012 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232DL2012PTC238218. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Lakhvinder Singh Arora (Director), Harpreet Singh Arora (Director), Rajan Chatterjee (Director). Past directors included Lalit Kumar Goel. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-4, Induastiral Area Phase-I Mayapuri, New Delhi, Delhi, 110064.
U24232DL2012PTC238218
238218
28 June 2012
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Novomax Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lakhvinder Singh Arora | Director | 01 Jun 2014 | Current |
| Harpreet Singh Arora | Director | 28 Jun 2012 | Current |
| Rajan Chatterjee | Director | 01 Jun 2014 | Current |
| Rajeev Anand | Director | 28 Jun 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jun 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novomax Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 30.69% decrease. The company also saw a substantial fall in profitability, with a 45.87% decrease in profit. The company's net worth Soared by an impressive increase of 14.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Novomax Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Novomax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novomax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novomax Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Novomax Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Novomax Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Lakhvinder Singh Arora was appointed as a Director was appointed as a Director on 01 Jun 2014 & has been associated with this company since 11 years 6 months . was completed.
The activity Rajan Chatterjee was appointed as a Director was appointed as a Director on 01 Jun 2014 & has been associated with this company since 11 years 6 months . was completed.
Progress on Harpreet Singh Arora was appointed as a Director was appointed as a Director on 28 Jun 2012 & has been associated with this company since 13 years 5 months . was documented.
Rajeev Anand was appointed as a Director was appointed as a Director on 28 Jun 2012 & has been associated with this company since 13 years 5 months . was recorded as a recent event.
The CIN of Novomax Pharma Private Limited is U24232DL2012PTC238218.
Novomax Pharma Private Limited is headquartered at A-4, Induastiral Area Phase-I Mayapuri, New Delhi, Delhi, 110064.
Novomax Pharma Private Limited was incorporated on 28 June 2012.
The current directors of Novomax Pharma Private Limited are
The primary industry of Novomax Pharma Private Limited is Trade.
Novomax Pharma Private Limited is unlisted.
The authorized capital of Novomax Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Novomax Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX